✦ LIBER ✦

Evaluation of COX-2 Selective Inhibitor for the Protection of Intestinal Mucosal Damage in Comparison to NSAIDs in Patients With Rheumatoid Arthritis

✍ Scribed by Inoue, Takahiro ;Iijima, Hideki ;Mukai, Akira ;Hayashi, Yoshito ;Akasaka, Tomofumi ;Kondo, Jumpei ;Nakajima, Sachiko ;Shinzaki, Shinichiro ;Nishida, Tsutomu ;Tsujii, Masahiko

Book ID: 122154570
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 134 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)61592-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of NSAIDs, N

Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis

✍ Hyung Ran Yun; Sang-Cheol Bae 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 209 KB

Development of clinically significant sy

Development of clinically significant systolic hypertension for the COX-2 selective inhibitor valdecoxib is similar to placebo and conventional NSAIDs in hypertensive patients with chronic arthritis

✍ William B. White; Andrew Whelton; Sharon X. Pan; Raymond Cheung 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

Economic Outcomes For Celecoxib In Latin

Economic Outcomes For Celecoxib In Latin America: A Cost-Effectiveness Study Of Cox-2 Inhibitors Against Nsaids+Ppi For Adult Patients With Osteoarthritis And Rheumatoid Arthritis In Brazil, Mexico, Colombia, Argentina And Costa Rica

✍ Mould-Quevedo, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB